Litigation Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)
✉ Email this page to a colleague
United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-09-16 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | 2023-07-24 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Parties | UNITED THERAPEUTICS CORPORATION | ||
| Patents | 10,036,054; 10,046,000; 6,521,212; 8,044,046; 8,497,393; 9,593,066; 9,604,901 | ||
| Attorneys | Adam William Burrowbridge | ||
| Firms | Direct: 949-620-6111, McDermott Will & Emery | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in United Therapeutics Corporation v. Liquidia Technologies, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in United Therapeutics Corporation v. Liquidia Technologies, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-10-06 | 15 | away on that? All the 10:36:54 5 witnesses you need, …claims for athird patent, the newly issued U.S. Patent No. 10,716,793 (the "`793 patent"). (D.I…Third, Patent Owner's reliance on claim 5of the ' 066 patent is unavailing. Patent Owner… Patent 9,604,901132 Patent Owner begins by contending that the ' 901 patent "…product from launching based solely on a patent—the ʼ793 patent—the PTAB has deemed unpatentable. The | External link to document | |
| 2023-01-23 | 30 | U.S. Patent No. 8,497,393 ’793 patent U.S. Patent No. 10,716,793 ’793 FWD … Full Term ’066 patent U.S. Patent No. 9,593,066 ’393 patent … 6, 8, 9 patent Asserted claims of the ’793 Claims 1, 4, 6, 7, 8 patent Asserted Patents …’793 Patent Claims Lack Written Description......... 12 D. The ’793 Patent Claims… Decision in IPR2021-00406 ’901 patent U.S. Patent No. 9,604,901 ʼ901 FWD | External link to document | |
| 2023-02-01 | 32 | U.S. Patent No. 8,497,393 ’793 patent U.S. Patent No. 10,716,793 ’793 FWD … Full Term ’066 patent U.S. Patent No. 9,593,066 ’393 patent … 6, 8, 9 patent Asserted claims of the ’793 Claims 1, 4, 6, 7, 8 patent Asserted Patents …’793 Patent Claims Lack Written Description......... 11 D. The ’793 Patent Claims… Decision in IPR2021-00406 ’901 patent U.S. Patent No. 9,604,901 ʼ901 FWD | External link to document | |
| 2023-02-13 | 36 | GLOSSARY ’066 Patent U.S. Patent No. 9,593,066 ’393 Patent U.S. Patent No. 8,497,393… Patent Trial and Appeal Board PTO U.S. Patent and Trademark Office… requirements of patentability,” id., including the ordinary “presumption of patent validity” enjoyed…product-by-process claims patentable. That is how product-by-process patents work. Liquidia also…claims 6 and 8 of the ’066 Patent and that claims 1, 2, 3, and 6 of the ’066 Patent are invalid as anticipated | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
